» Articles » PMID: 26944318

MicroRNA-379-5p Inhibits Tumor Invasion and Metastasis by Targeting FAK/AKT Signaling in Hepatocellular Carcinoma

Overview
Journal Cancer Lett
Specialty Oncology
Date 2016 Mar 6
PMID 26944318
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

Some microRNAs (miRNAs) have been implicated in hepatocellular carcinoma (HCC) development and progression. However, the roles and mechanisms of several miRNAs in HCC remain poorly understood. Here, we report that miR-379-5p, which is down-regulated in HCC tissues and cell lines, is associated with advanced TNM stage and metastasis in HCC. The ectopic overexpression of miR-379-5p inhibited HCC cell migration, invasion, epithelial-to-mesenchymal transition (EMT) and metastasis both in vitro and in vivo. Conversely, miR-379 knockdown increased migration, invasion and EMT in HCC cells. Moreover, miR-379-5p exerted this function by directly targeting focal adhesion kinase (FAK) 3'-UTR and repressing FAK expression, thus leading to suppression of AKT signaling. Furthermore, the tumor suppressive effects of miR-379-5p in HCC cells were reversed by activating AKT signaling or restoring FAK expression. In clinical samples of HCC, miR-379-5p negatively correlated with FAK, which was up-regulated in HCC. Taken together, our findings highlight the important role of miR-379-5p in regulating the EMT and metastasis of HCC by targeting FAK/AKT signaling, suggesting that miR-379-5p may represent a novel potential therapeutic target and prognostic marker for HCC.

Citing Articles

hsa_circ_0008305 facilitates the malignant progression of hepatocellular carcinoma by regulating AKR1C3 expression and sponging miR-379-5p.

Huang S, Liu K, Xu Y, Wang H, Fu S, Wu J Sci Rep. 2025; 15(1):1309.

PMID: 39779892 PMC: 11711494. DOI: 10.1038/s41598-025-85737-1.


Genes of DLK1-DIO3 Locus and miR-379/656 Cluster is a Potential Diagnostic and Prognostic Marker in Patients With Hepatocellular Carcinoma: A Systems Biology Study.

Karunakara S, Mehtani R, Kabekkodu S, Kumar D, Santhekadur P J Clin Exp Hepatol. 2024; 15(2):102450.

PMID: 39698049 PMC: 11650283. DOI: 10.1016/j.jceh.2024.102450.


miR-379-5p affects breast cancer cell behavior by targeting UBE2E3 ubiquitin conjugating enzyme.

Schroder A, Loy C, Aiala F, Rafique J, Ghosh A, Yoo L PLoS One. 2024; 19(12):e0310315.

PMID: 39621672 PMC: 11611187. DOI: 10.1371/journal.pone.0310315.


MicroRNA as Key Players in Hepatocellular Carcinoma: Insights into Their Role in Metastasis.

Saadh M, Hussain Q, Alazzawi T, Fahdil A, Athab Z, Yarmukhamedov B Biochem Genet. 2024; .

PMID: 39103713 DOI: 10.1007/s10528-024-10897-0.


Expression of microRNA-379 reduces metastatic spread of prostate cancer.

Cassidy J, Voss G, Underbjerg K, Persson M, Ceder Y Front Oncol. 2023; 13:1252915.

PMID: 37781173 PMC: 10539900. DOI: 10.3389/fonc.2023.1252915.